Considerations for Mean Upper Cervical Cord Area Implementation in a Longitudinal MRI Setting: Methods, Interrater Reliability, and MRI Quality Control

References

1. 1.↵
   1. Brownlee WJ,
   2. Altmann DR,
   3. Alves Da Mota P, et al

   . Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 2017;23:665–74 doi:10.1177/1352458516663034 pmid:27481210

   CrossRefPubMed
2. 2.↵
   1. Tsagkas C,
   2. Magon S,
   3. Gaetano L, et al

   . Preferential spinal cord volume loss in primary progressive multiple sclerosis. Mult Scler 2019;25:947–57 doi:10.1177/1352458518775006 pmid:29781383

   CrossRefPubMed
3. 3.↵
   1. Chien C,
   2. Scheel M,
   3. Schmitz-Hübsch T, et al

   . Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler 2019;25:1926–36 doi:10.1177/1352458518815596 pmid:30475082

   CrossRefPubMed
4. 4.↵
   1. Zeydan B,
   2. Gu X,
   3. Atkinson EJ, et al

   . Cervical spinal cord atrophy: an early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm 2018;5:e435 doi:10.1212/NXI.0000000000000435 pmid:29435472

   Abstract/FREE Full Text
5. 5.↵
   1. Ciccarelli O,
   2. Cohen JA,
   3. Reingold SC, et al

   ; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol 2019;18:185–97 doi:10.1016/S1474-4422(18)30460-5 pmid:30663608

   CrossRefPubMed
6. 6.↵
   1. Sinnecker T,
   2. Granziera C,
   3. Wuerfel J, et al

   . Future brain and spinal cord volumetric imaging in the clinic for monitoring treatment response in MS. Curr Treat Options Neurol 2018;20:17 doi:10.1007/s11940-018-0504-7 pmid:29679165

   CrossRefPubMed
7. 7.↵
   1. Alcaide-Leon P,
   2. Cybulsky K,
   3. Sankar S, et al

   . Quantitative spinal cord MRI in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm 2018;5:e436 doi:10.1212/NXI.0000000000000436 pmid:29359174

   Abstract/FREE Full Text
8. 8.↵
   1. Chien C,
   2. Brandt AU,
   3. Schmidt F, et al

   . MRI-based methods for spinal cord atrophy evaluation: a comparison of cervical cord cross-sectional area, cervical cord volume, and full spinal cord volume in patients with aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders. AJNR Am J Neuroradiol 2018;39:1362–68 doi:10.3174/ajnr.A5665 pmid:29748202

   Abstract/FREE Full Text
9. 9.↵
   1. Moccia M,
   2. Ruggieri S,
   3. Ianniello A, et al

   . Advances in spinal cord imaging in multiple sclerosis. Ther Adv Neurol Disord 2019;12:1756286419840593 doi:10.1177/1756286419840593 pmid:31040881

   CrossRefPubMed
10. 10.↵
    1. Valsasina P,
    2. Aboulwafa M,
    3. Preziosa P, et al

    . Cervical cord T1-weighted hypointense lesions at MR imaging in multiple sclerosis: relationship to cord atrophy and disability. Radiology 2018;288:234–44 doi:10.1148/radiol.2018172311 pmid:29664341

    CrossRefPubMed
11. 11.↵
    1. Filippi M,
    2. Rocca MA,
    3. Ciccarelli O, et al

    ; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
12. 12.↵
    1. Prados F,
    2. Barkhof F

    . Spinal cord atrophy rates: ready for prime time in multiple sclerosis clinical trials? Neurology 2018;91:157–58 doi:10.1212/WNL.0000000000005873 pmid:29950433

    CrossRefPubMed
13. 13.↵
    1. Lammertse D,
    2. Dungan D,
    3. Dreisbach J, et al

    ; National Institute on Disability and Rehabilitation. Neuroimaging in traumatic spinal cord injury: an evidence-based review for clinical practice and research. J Spinal Cord Med 2007;30:205–14 doi:10.1080/10790268.2007.11753928 pmid:17684886

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Seif M,
    2. Wheeler-Kingshott CA,
    3. Cohen-Adad J, et al

    . Guidelines for the conduct of clinical trials in spinal cord injury: neuroimaging biomarkers. Spinal Cord 2019;57:717–28 doi:10.1038/s41393-019-0309-x pmid:31267015

    CrossRefPubMed
15. 15.↵
    1. Nouri A,
    2. Martin AR,
    3. Mikulis D, et al

    . Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques. Neurosurg Focus 2016;40:E5 doi:10.3171/2016.3.FOCUS1667 pmid:27246488

    CrossRefPubMed
16. 16.↵
    1. Casserly C,
    2. Seyman EE,
    3. Alcaide‐
    4. Leon P, et al

    . Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis. J Neuroimaging 2018;28:556–86 doi:10.1111/jon.12553 pmid:30102003

    CrossRefPubMed
17. 17.↵
    1. Papinutto N,
    2. Bakshi R,
    3. Bischof A, et al

    ; North American Imaging in Multiple Sclerosis Cooperative (NAIMS). Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1-weighted brain MRI acquisitions. Magn Reson Med 2018;79:1595–601 doi:10.1002/mrm.26776 pmid:28617996

    CrossRefPubMed
18. 18.↵
    1. Filevich E,
    2. Lisofsky N,
    3. Becker M, et al

    . Day2day: investigating daily variability of magnetic resonance imaging measures over half a year. BMC Neurosci 2017;18:65 doi:10.1186/s12868-017-0383-y pmid:28836958

    CrossRefPubMed
19. 19.↵
    1. Tustison NJ,
    2. Avants BB,
    3. Cook PA, et al

    . N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 2010;29:1310–20 doi:10.1109/TMI.2010.2046908 pmid:20378467

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Horsfield MA,
    2. Sala S,
    3. Neema M, et al

    . Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage 2010;50:446–55 doi:10.1016/j.neuroimage.2009.12.121 pmid:20060481

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Valsasina P,
    2. Horsfield MA,
    3. Rocca MA, et al

    . Spatial normalization and regional assessment of cord atrophy: voxel-based analysis of cervical cord 3D T1-weighted images. AJNR Am J Neuroradiol 2012;33:2195–200 doi:10.3174/ajnr.A3139 pmid:22678848

    Abstract/FREE Full Text
22. 22.↵
    1. De Leener B,
    2. Kadoury S,
    3. Cohen-Adad J

    . Robust, accurate and fast automatic segmentation of the spinal cord. NeuroImage 2014;98:528–36 doi:10.1016/j.neuroimage.2014.04.051 pmid:24780696

    CrossRefPubMed
23. 23.↵
    1. Ho J,
    2. Tumkaya T,
    3. Aryal S, et al

    . Moving beyond P values: data analysis with estimation graphics. Nat Methods 2019;16:565–66 doi:10.1038/s41592-019-0470-3 pmid:31217592

    CrossRefPubMed
24. 24.↵
    1. Feltz CJ,
    2. Miller GE

    . An asymptotic test for the equality of coefficients of variation from k populations. Stat Med 1996;15:646–58 doi:10.1002/(sici)1097-0258(19960330)15:6<647::aid-sim184>3.0.co;2-p pmid:8731006

    CrossRefPubMed
25. 25.↵
    1. Beckerman H,
    2. Roebroeck ME,
    3. Lankhorst GJ, et al

    . Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 2001;10:571–78 doi:10.1023/a:1013138911638 pmid:11822790

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Core Team R

    . R: A language and environment for statistical computing. Vienna; R Foundation for Statistical Computing; 2019
27. 27.↵
    1. Weeda MM,
    2. Middelkoop SM,
    3. Steenwijk MD, et al

    . Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): high reproducibility and robustness to lesions, but large software and scanner effects. Neuroimage Clin 2019;24:101962 doi:10.1016/j.nicl.2019.101962 pmid:31416017

    CrossRefPubMed
28. 28.↵
    1. Yiannakas MC,
    2. Mustafa AM,
    3. De Leener B, et al

    . Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: application to multiple sclerosis. Neuroimage Clin 2016;10:71–77 doi:10.1016/j.nicl.2015.11.001 pmid:26793433

    CrossRefPubMed
29. 29.↵
    1. Gros C,
    2. De Leener B,
    3. Badji A, et al

    . Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. Neuroimage 2019;184:901–15 doi:10.1016/j.neuroimage.2018.09.081 pmid:30300751

    CrossRefPubMed
30. 30.↵
    1. Liu Y,
    2. Lukas C,
    3. Steenwijk MD, et al

    . Multicenter validation of mean upper cervical cord area measurements from head 3D T1-weighted MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol 2016;37:749–54 doi:10.3174/ajnr.A4635 pmid:26659338

    Abstract/FREE Full Text
31. 31.↵
    1. Valsasina P,
    2. Rocca MA,
    3. Horsfield MA, et al

    . A longitudinal MRI study of cervical cord atrophy in multiple sclerosis. J Neurol 2015;262:1622–28 doi:10.1007/s00415-015-7754-z pmid:25929665

    CrossRefPubMed
32. 32.↵
    1. Kato F,
    2. Yukawa Y,
    3. Suda K, et al

    . Normal morphology, age-related changes and abnormal findings of the cervical spine, Part II: magnetic resonance imaging of over 1,200 asymptomatic subjects. Eur Spine J 2012;21:1499–507 doi:10.1007/s00586-012-2176-4 pmid:22302162

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Yanase M,
    2. Matsuyama Y,
    3. Hirose K, et al

    . Measurement of the cervical spinal cord volume on MRI. J Spinal Disord Tech 2006;19:125–29 doi:10.1097/01.bsd.0000181294.67212.79 pmid:16760787

    CrossRefPubMed
34. 34.↵
    1. Trefler A,
    2. Sadeghi N,
    3. Thomas AG, et al

    . Impact of time-of-day on brain morphometric measures derived from T1-weighted magnetic resonance imaging. Neuroimage 2016;133:41–52 doi:10.1016/j.neuroimage.2016.02.034 pmid:26921714

    CrossRefPubMed
35. 35.↵
    1. Wang C,
    2. Tam RC,
    3. Mackie E, et al

    . Dehydration affects spinal cord cross-sectional area measurement on MRI in healthy subjects. Spinal Cord 2014;52:616–20 doi:10.1038/sc.2014.66 pmid:24777158

    CrossRefPubMed